CSK and neoplasm: This study demonstrates that the efficient encapsulation of the inhibitor of the c-Src tyrosine kinase, Si306 into pegylated stealth liposomes decorated with anti-GD2 mAbs improves its anti-tumor effects, compared to Si306, either free or encapsulated into untargeted liposomes, against human neuroblastoma (NB) cells.